ArticleInternational journal of paediatric dentistry2026
Streptococcus mutans Growth Inhibition by the Probiotic Lacticaseibacillus rhamnosus GG as an Additive to Infant Formula.
Article in International journal of paediatric dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Probiotics have demonstrated Streptococcus mutans (SM) suppression. This in vitro study compared the SM inhibition capacity of bovine infant formula supplemented with Lacticaseibacillus rhamnosus Gorbach Goldin (LGG) probiotic to a plain formulation.
methodsTwo bovine-based infant formulas, Similac Advance Optigro (formula non-probiotic, FNP) and Enfamil Nutramigen LGG (formula with probiotic, FWP) were compared. The formulas were reconstituted at different concentrations (0.1×, 0.5×, 1×, and 2×). LGG (ATCC BAA-3227) suspensions were used as positive controls. All assays were inoculated with SM, spiral plated (n = 8) onto selective Mitis Salivarius Agar plates, and incubated at 37°C for 96 h. SM growth was enumerated in colony-forming units (CFU). Multivariate analysis of variance was performed to assess concentration-dependent effects and statistical significance (α = 0.05).
resultsFWP recorded less SM growth than FNP at the 0.5×, 1.0×, and 2.0× concentrations (ANOVA p < 0.001). FWP concentration was negatively correlated to SM growth (p < 0.001, r = -0.864), whereas FNP showed strong positive trends (p < 0.001, r = 0.821). MANOVA tests confirmed that both group and concentration affect SM growth (p < 0.001).
conclusionCommercial probiotic-enriched infant formula effectively suppresses SM growth in vitro. The observed suppression of SM growth in this study provides evidence for this dietary intervention's anticariogenic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.